as 07-26-2024 4:00pm EST
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
Founded: | 1992 | Country: | United States |
Employees: | N/A | City: | SALT LAKE CITY |
Market Cap: | 904.5M | IPO Year: | 1996 |
Target Price: | $38.00 | AVG Volume (30 days): | 91.9K |
Analyst Decision: | Hold | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 3.21 | EPS Growth: | -5.31 |
52 Week Low/High: | $40.51 - $67.32 | Next Earning Date: | 07-23-2024 |
Revenue: | $900,450,000 | Revenue Growth: | -7.56% |
Revenue Growth (this year): | -2.24% | Revenue Growth (next year): | 3.70% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
WENTZ MYRON W | USNA | 10% Owner | Jun 12 '24 | Sell | $45.03 | 13,496 | $607,724.88 | 7,864,345 | SEC Form 4 |
WENTZ MYRON W | USNA | 10% Owner | Jun 12 '24 | Sell | $47.79 | 2,202 | $105,233.58 | 7,877,841 | SEC Form 4 |
WENTZ MYRON W | USNA | 10% Owner | Jun 7 '24 | Sell | $48.61 | 3,700 | $179,857.00 | 7,880,043 | SEC Form 4 |
Jones Paul A. | USNA | CHIEF PEOPLE OFFICER | May 22 '24 | Sell | $48.66 | 2,714 | $132,063.51 | 6,266 | SEC Form 4 |
IIEKKING G DOUG | USNA | CHIEF FINANCIAL OFFICER | May 7 '24 | Sell | $44.76 | 5,198 | $232,676.51 | 0 | SEC Form 4 |
FULLER GILBERT A | USNA | Director | May 7 '24 | Sell | $44.59 | 490 | $21,848.61 | 0 | SEC Form 4 |
Macuga Daniel A. | USNA | CHIEF COMMUNICATIONS OFFICER | May 2 '24 | Sell | $47.14 | 3,791 | $178,716.84 | 0 | SEC Form 4 |
Macuga Daniel A. | USNA | CHIEF COMMUNICATIONS OFFICER | May 2 '24 | Sell | $47.14 | 3,791 | $178,716.84 | 0 | SEC Form 4 |
Guest Kevin | USNA | EXEC. CHAIRMAN OF THE BOARD | Mar 11 '24 | Sell | $49.00 | 11,011 | $539,539.00 | 10,491 | SEC Form 4 |
Noot Walter | USNA | CHIEF OPERATING OFFICER | Mar 8 '24 | Sell | $49.05 | 5,240 | $257,022.00 | 0 | SEC Form 4 |
Neidig Brent | USNA | CO. & MAN. DIR. OF CHINA | Mar 6 '24 | Sell | $47.00 | 3,810 | $179,066.19 | 0 | SEC Form 4 |
SINNOTT ROBERT A | USNA | CHIEF SCIENTIFIC OFFICER | Mar 5 '24 | Sell | $46.56 | 3,945 | $183,659.48 | 0 | SEC Form 4 |
Fleming John Turman | USNA | Director | Mar 4 '24 | Sell | $48.99 | 300 | $14,696.46 | 3,013 | SEC Form 4 |
FULLER GILBERT A | USNA | Director | Mar 4 '24 | Sell | $49.07 | 491 | $24,095.73 | 0 | SEC Form 4 |
Macuga Daniel A. | USNA | CHIEF COMMUNICATIONS OFFICER | Mar 1 '24 | Sell | $48.08 | 1,500 | $72,120.00 | 3,791 | SEC Form 4 |
Foukas Joshua | USNA | CHIEF LEGAL OFFICER | Feb 29 '24 | Sell | $47.91 | 4,847 | $232,234.31 | 0 | SEC Form 4 |
Pelosi Peggie | USNA | Director | Feb 29 '24 | Sell | $48.15 | 485 | $23,350.81 | 3,138 | SEC Form 4 |
Mulham David Mulham | USNA | CHIEF SALES OFFICER | Feb 29 '24 | Sell | $47.76 | 4,311 | $205,871.81 | 7,825 | SEC Form 4 |
Fleming John Turman | USNA | Director | Dec 12 '23 | Sell | $49.73 | 312 | $15,514.89 | 2,822 | SEC Form 4 |
FULLER GILBERT A | USNA | Director | Nov 3 '23 | Sell | $46.01 | 490 | $22,546.27 | 0 | SEC Form 4 |
USNA Breaking Stock News: Dive into USNA Ticker-Specific Updates for Smart Investing
StockStory
16 hours ago
StockStory
2 days ago
Argus Research
3 days ago
Zacks
3 days ago
Associated Press Finance
3 days ago
StockStory
3 days ago
Business Wire
3 days ago
StockStory
5 days ago
The information presented on this page, "USNA USANA Health Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.